Having trouble accessing articles? Reset your cache.

Biosimilar rituximab: Phase III start

Celltrion said it plans to start a Phase III trial of CT-P10 in 2H13. Celltrion had planned to conduct Phase I and

Read the full 226 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE